SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-22-000108
Filing Date
2022-09-23
Accepted
2022-09-23 08:09:14
Documents
18
Period of Report
2022-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K optn-20220920.htm   iXBRL 8-K 38472
2 EX-10.1 amd2toflexagmtdsa2022090.htm EX-10.1 10563
6 amd2toflexagmtdsa2022090001.jpg GRAPHIC 249117
7 amd2toflexagmtdsa2022090002.jpg GRAPHIC 236017
8 amd2toflexagmtdsa2022090003.jpg GRAPHIC 87762
9 amd2toflexagmtdsa2022090004.jpg GRAPHIC 85402
10 optn-20220920_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-22-000108.txt   1132493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20220920.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20220920_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20220920_pre.xml EX-101.PRE 13581
12 EXTRACTED XBRL INSTANCE DOCUMENT optn-20220920_htm.xml XML 11806
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 221260642
SIC: 2834 Pharmaceutical Preparations